FDA Inspection 1110665 — National Jewish Health IRB

National Jewish Health IRB — FEI 1718797

The FDA completed an inspection of National Jewish Health IRB on Oct 28, 2019 in Denver, CO. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Drugs.

Inspection details

Classification
No Action Indicated (NAI)
End Date
Oct 28, 2019
Fiscal Year
2020
Product Type
Drugs
Project Area
Bioresearch Monitoring
Location
Denver, CO (United States)

Additional details

IRB

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.